Increased Cavernous Expression of Transforming Growth Factor-β1 and Activation of the Smad Signaling Pathway Affects Erectile Dysfunction in Men with Spinal Cord Injury

被引:21
|
作者
Shin, Tae-Young [1 ,2 ]
Ryu, Ji-Kan [1 ,2 ]
Jin, Hai-Rong [1 ,2 ]
Piao, Shuguang [1 ,2 ]
Tumurbaatar, Munkhbayar [1 ,2 ]
Yin, Guo Nan [1 ,2 ]
Shin, Sun Hwa [1 ,2 ]
Kwon, Mi-Hye [1 ,2 ]
Song, Kang-Moon [1 ,2 ]
Fang, Zheng-Huan [1 ,2 ]
Han, Jee-Young [3 ]
Kim, Woo Jean [1 ,2 ]
Suh, Jun-Kyu [1 ,2 ]
机构
[1] Inha Univ, Sch Med, Natl Res Lab Regenerat Sexual Med, Inchon 400711, South Korea
[2] Inha Univ, Sch Med, Dept Urol, Inchon 400711, South Korea
[3] Inha Univ, Sch Med, Dept Pathol, Inchon 400711, South Korea
来源
JOURNAL OF SEXUAL MEDICINE | 2011年 / 8卷 / 05期
关键词
Spinal Cord Injury; Erectile Dysfunction; Transforming Growth Factor-Beta; Smad; Fibrosis; I RECEPTOR KINASE; SMOOTH-MUSCLE; CORPUS CAVERNOSUM; GROWTH FACTOR-BETA(1); ENDOTHELIAL-CELLS; PEYRONIES-DISEASE; RAT MODEL; INHIBITOR; FIBROSIS; TESTOSTERONE;
D O I
10.1111/j.1743-6109.2010.02049.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Transforming growth factor-beta 1 (TGF-beta 1) is implicated in bladder fibrosis after spinal cord injury (SCI) and in the fibrosis in the corpus cavernosum tissue after cavernous nerve injury. Aim. We investigated the differential expression of TGF-beta 1 and the Smad transcription factor, the key molecule for the initiation of TGF-beta-mediated fibrosis, in cavernous tissue from SCI patients. Methods. After obtaining informed consent and approval from the patients and our institutional review board, we enrolled 5 patients with psychogenic erectile dysfunction (ED) (mean age 36.8 years; range 20-50 years) and 10 patients with neurogenic ED from SCI (mean age 38.8 years; range 18-50 years). Cavernous tissues were obtained by percutaneous biopsy and stained with Masson trichrome, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL), or antibodies to TGF-beta 1 and phospho-Smad2. Main Outcome Measures. Semi-quantitative analysis of TGF-beta 1 and phospho-Smad2 was performed, and the numbers of apoptotic cells were counted. We also quantified the cavernous collagen area with the use of an image analyzer system. Results. The expression of TGF-beta 1 and phospho-Smad2 protein was significantly higher in the SCI group than in the psychogenic group. The TUNEL assay revealed a higher apoptotic index in the SCI group than in the psychogenic group. Higher TGF-beta 1 and phospho-Smad2 expression and more apoptotic cells were noted mainly in endothelial cells, smooth muscle cells, and fibroblasts of the SCI group. Double labeling of cavernous tissue with TUNEL and antibody to phospho-Smad2 revealed that most TUNEL-positive cells showed immunoreactivity to phospho-Smad2 staining. Cavernous collagen content was significantly greater in the SCI group than in the psychogenic group. Conclusion. Upregulation of TGF-beta 1 and activation of the Smad signaling pathway may play important roles in SCI-induced cavernous fibrosis and deterioration of erectile function, which warrants early pharmacological intervention to protect erectile tissue from irreversible damage. Shin T-Y, Ryu J-K, Jin H-R, Piao S, Tumurbaatar M, Yin GN, Shin SH, Kwon M-H, Song K-M, Fang Z-H, Han J-Y, Kim WJ, and Suh J-K. Increased cavernous expression of transforming growth factor-beta 1 and activation of the smad signaling pathway affects erectile dysfunction in men with spinal cord injury. J Sex Med 2011;8:1454-1462.
引用
收藏
页码:1454 / 1462
页数:9
相关论文
共 50 条
  • [21] Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-β
    FANG Xiangqian FANG Mei FAN Shunwu GU Chuanlong Department of OrthopaedicsSir Run Run Shaw HospitalSchool of MedicineZhejiang UniversityHangzhouZhejiang China Sir Run Run Shaw Hospital School of Medicine Zhejiang UniversityHangzhouZhejiang ChinaDepartment of Cell Biology and AnatomySchool of MedicineZhejiang UniversityHangzhouZhejiang China
    中华医学杂志(英文版), 2009, (14) : 1631 - 1635
  • [22] Increased Expression of the Transforming Growth Factor-β Signaling Pathway, Endoglin, and Early Growth Response-1 in Stable Plaques
    Bot, Pieter T. G.
    Hoefer, Imo E.
    Sluijter, Joost P. G.
    van Vliet, Patrick
    Smits, Anke M.
    Lebrin, Franck
    Moll, Frans
    de Vries, Jean-Paul
    Doevendans, Pieter
    Piek, Jan J.
    Pasterkamp, Gerard
    Goumans, Marie-Jose
    STROKE, 2009, 40 (02) : 439 - 447
  • [23] Activation of the Transforming Growth Factor-β/Activin Signaling Pathway in Human Atherosclerosis
    Oklu, Rahmi
    Hesketh, Robin
    Wicky, Stephan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E293 - E293
  • [24] Inhibition of transforming growth factor-β/Smad signaling by phosphatidylinositol 3-kinase pathway
    Qiao, Jingbo
    Kang, Junghee
    Ko, Tien C.
    Evers, B. Mark
    Chung, Dai H.
    CANCER LETTERS, 2006, 242 (02) : 207 - 214
  • [25] The transforming growth factor-β/SMAD signaling pathway is present and functional in human mesangial cells
    Poncelet, AC
    de Caestecker, MP
    Schnaper, HW
    KIDNEY INTERNATIONAL, 1999, 56 (04) : 1354 - 1365
  • [26] Localization of transforming growth factor-β1 and receptor mRNA after experimental spinal cord injury
    McTigue, DM
    Popovich, PG
    Morgan, TE
    Stokes, BT
    EXPERIMENTAL NEUROLOGY, 2000, 163 (01) : 220 - 230
  • [27] The role of thrombospondin-1 and transforming growth factor-β after spinal cord injury in the rat
    Wang, Xianghua
    Chen, Weiping
    Liu, Wangmi
    Wu, Jiayan
    Shao, Yanqi
    Zhang, Xiaoming
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (06) : 818 - 821
  • [28] Sustained activation of fibroblast transforming growth Factor-β/Smad signaling in a murine model of scleroderma
    Takagawa, S
    Lakos, G
    Mori, Y
    Yamamoto, T
    Nishioka, K
    Varga, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (01) : 41 - 50
  • [29] Transforming growth factor-β receptor type 2 is required for heparin-binding protein-induced acute lung injury and vascular leakage for transforming growth factor-β/Smad/Rho signaling pathway activation
    Liu, Zixuan
    Chen, Mingming
    Sun, Yini
    Li, Xu
    Cao, Liu
    Ma, Xiaochun
    FASEB JOURNAL, 2022, 36 (11):
  • [30] CTRP3 attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway
    Cheng, Chuantao
    Yu, Shuo
    Kong, Ran
    Yuan, Qinggong
    Ma, Yuefeng
    Yang, Wenbin
    Cao, Gang
    Xie, Liyi
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 1387 - 1391